Nutex Health (NUTX)
Nasdaq Market Closed
Nutex Health Inc. is a US healthcare services company built around physician-led hospital operations and population health management. The company focuses on smaller-format care facilities, including micro-hospitals, specialty hospitals and hospital outpatient departments, with an operating model intended to combine emergency care access with streamlined inpatient and outpatient services.
The business is organised into three main segments: Hospital, Population Health Management and Real Estate. The Hospital division is the largest contributor to revenue and is responsible for implementing, staffing and operating Nutex’s healthcare facilities. Its model generally centres on facilities that are smaller than traditional community hospitals but designed to provide acute care capabilities in local markets.
The Population Health Management division operates provider networks, including independent physician associations, and participates in risk-bearing care arrangements. This part of the company is tied to the broader shift in US healthcare toward value-based care, where providers may be compensated based on patient outcomes, cost management and coordinated care rather than only fee-for-service activity.
Nutex also has a Real Estate division that owns certain land and hospital buildings used by its hospital entities. These properties are leased to operating facilities, creating an internal infrastructure layer that supports the company’s healthcare delivery model.
As a listed healthcare stock, Nutex gives investors exposure to a niche mix of hospital operations, physician networks and healthcare real estate. Its performance is influenced by patient volumes, reimbursement rates, payer relationships, facility-level profitability and the execution of its population health strategy.
Last updated
- Market Cap
- 929.67M
- P/E
- 9.65
- P/FCF
- 3.46
- P/S
- 1.06
- Enterprise Value
- 1.04B
- Sector
- Industrials
- Industry
- Business Services, Not Elsewhere Classified
- Address
- 1776 YORKTOWN ST, HOUSTON, TX, 77056
$ALDX ALERT: Aldeyra Therapeutics, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Lowey Dannenberg, P.C. is Investigating Nutex Health, Inc. (Nasdaq: NUTX) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NUTX 3-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
Shareholders of Nutex Health Inc. Should Contact The Gross Law Firm Before October 21, 2025 to Discuss Your Rights – NUTX
NUTX 5-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman
DEADLINE ALERT for PUBM, SNAP, NUTX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
Lost Money on Dow Inc.(DOW)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
NUTX DEADLINE: ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Deadline Alert: Nutex Health Inc. (NUTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
NUTX DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Nutex Health Inc. (NUTX) Shareholders
NUTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
NUTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nutex Health Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NUTX INVESTORS: Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Important Deadline in Class Action Lawsuit
NUTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 929.67M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.04B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 9.65
- P/B
P/B ratio compares a company's share price to its book value per share.
- 2.68
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.06
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 3.5
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.18
- EPS
- 14.01
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.02%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 3.46
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 3.41
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 269.02M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 27.83%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 10.07%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.92
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.12
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.1
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.12
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 158K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 135.1
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 216.49M | 151.68M | 267.8M | 243.99M | 211.79M |
| Gross profit | 216.49M | 151.68M | 267.8M | 243.99M | 211.79M |
| Operating income | 81.27M | 30.92M | 130.37M | 33.68M | 80.66M |
| EBITDA | 86.76M | 36.11M | 135.37M | 38.93M | 85.75M |
| Net income | 46.81M | 11.83M | 55.44M | -17.7M | 21.22M |
| Basic EPS | 6.7 | 1.5 | 8.27 | -2.95 | 3.74 |
| Diluted EPS | 6.52 | 1.61 | 7.76 | -2.95 | 3.33 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 957.32M | 918.53M | 964.52M | 841.03M | 761.92M |
| Total liabilities | 515.27M | 495.09M | 526.49M | 504.15M | 506.65M |
| Total equity | 442.05M | 423.44M | 438.03M | 336.88M | 255.27M |
| Cash & equivalents | 207.35M | 185.57M | 166.05M | 96.73M | 84.73M |
| Current assets | 576.36M | 538.51M | 592.65M | 473.03M | 398.58M |
| Current liabilities | 184.44M | 157.91M | 185.46M | 194.87M | 196.18M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 75.52M | 70.39M | 99.51M | 27.26M | 50.97M |
| Investing cash flow | -1.2M | -5.07M | -302K | 196K | -64K |
| Financing cash flow | -49.55M | -45.79M | -29.9M | -15.45M | -6.81M |
| Change in cash | 24.77M | 19.53M | 69.32M | 12M | 44.09M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| edgar index | SCHEDULE 13G/A — Nutex Health Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 8-K — Nutex Health Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Jaumot Frank E | View Filing | |
| form 4 | Form 4 — Grenas Cheryl Yvonne | View Filing | |
| form 4 | Form 4 — Reed Michael Lee | View Filing | |
| form 4 | Form 4 — Saunders Scott J | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Jaumot Frank E | View Filing | |
| form 4 | Form 4 — Hosseinion Warren | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Spears Kelvin | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | DEF 14A — Nutex Health Inc. | View Filing | |
| edgar index | DEFA14A — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Montgomery Pamela W. | View Filing | |
| edgar index | S-8 POS — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| edgar index | 4 — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Bates Jon Christian | View Filing | |
| form 4 | Form 4 — Bamburg Wesley Shane | View Filing | |
| edgar index | SCHEDULE 13G — Nutex Health Inc. | View Filing | |
| form 4 | Form 4 — Hosseinion Warren | View Filing | |
| form 4 | Form 4 — Hosseinion Warren | View Filing | |
| form 4 | Form 4 — Hosseinion Warren | View Filing | |
| form 4 | Form 4 — Hosseinion Warren | View Filing | |
| form 4 | Form 4 — Luqman Elisa V | View Filing | |
| form 4 | Form 4 — Luqman Elisa V | View Filing | |
| form 4 | Form 4 — Luqman Elisa V | View Filing | |
| form 4 | Form 4 — Montgomery Pamela W. | View Filing | |
| form 4 | Form 4 — Montgomery Pamela W. | View Filing | |
| form 4 | Form 4 — Montgomery Pamela W. | View Filing | |
| form 4 | Form 4 — Montgomery Pamela W. | View Filing | |
| form 4 | Form 4 — Chang Michael L. | View Filing | |
| form 4 | Form 4 — Chang Michael L. | View Filing | |
| form 4 | Form 4 — Chang Michael L. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| form 4 | Form 4 — Vo Thomas T. | View Filing | |
| form 4 | Form 4 — Bates Jon Christian | View Filing | |
| form 4 | Form 4 — Spears Kelvin | View Filing | |
| form 4 | Form 4 — Spears Kelvin | View Filing | |
| form 4 | Form 4 — Spears Kelvin | View Filing | |
| form 4 | Form 4 — Spears Kelvin | View Filing | |
| edgar index | S-8 — Nutex Health Inc. | View Filing | |
| edgar index | 10-K — Nutex Health Inc. | View Filing | |
| edgar index | 8-K — Nutex Health Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — Nutex Health, Inc. | View Filing | |
| edgar index | 4 — Nutex Health, Inc. | View Filing | |
| edgar index | 4 — Nutex Health, Inc. | View Filing | |
| edgar index | 4 — Nutex Health, Inc. | View Filing | |
| edgar index | 4 — Nutex Health, Inc. | View Filing | |
| edgar index | 4 — Nutex Health, Inc. | View Filing | |
| form 4 | Form 4 — Bates Jon Christian | View Filing |